Jolinda de Korne-Elenbaas

Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial

Henry J.C. de Vries, Myrthe de Laat, Vita W. Jongen et al. · The Lancet Infectious Diseases · 2022 · 60 citations

Gynecology, Non-inferiority Trial, Medicine +2

Emergence of a <i>Neisseria gonorrhoeae</i> clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis

Jolinda de Korne-Elenbaas, Sylvia M. Bruisten, Henry J.C. de Vries et al. · Journal of Antimicrobial Chemotherapy · 2021 · 32 citations · Full text

Sudden emergence of a Neisseria gonorrhoeae clade with reduced susceptibility to extended-spectrum cephalosporins, Norway

Magnus N Osnes, Xavier Didelot, Jolinda de Korne-Elenbaas et al. · Microbial Genomics · 2020 · 20 citations · Full text

The Neisseria gonorrhoeae Accessory Genome and Its Association with the Core Genome and Antimicrobial Resistance

Jolinda de Korne-Elenbaas, Sylvia M. Bruisten, Alje P. van Dam et al. · Microbiology Spectrum · 2022 · 20 citations · Full text

Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics

Jolinda de Korne-Elenbaas, Arno C. Pol, Jacqueline E. H. M. Vet et al. · Sexually Transmitted Diseases · 2020 · 16 citations · Full text